Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Analysis of the structure of empty and peptide-loaded major histocompatibility complex molecules at the cell surface.

Catipović B, Talluri G, Oh J, Wei T, Su XM, Johansen TE, Edidin M, Schneck JP.

J Exp Med. 1994 Nov 1;180(5):1753-61.

2.

T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.

Morkowski S, Goldrath AW, Eastman S, Ramachandra L, Freed DC, Whiteley P, Rudensky AYu.

J Exp Med. 1995 Nov 1;182(5):1403-13.

3.

The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.

Kambayashi T, Kraft-Leavy JR, Dauner JG, Sullivan BA, Laur O, Jensen PE.

J Immunol. 2004 Feb 1;172(3):1661-9.

4.

Role of conserved regions of class I MHC molecules in the activation of CD8+ cytotoxic T lymphocytes by peptide and purified cell-free class I molecules.

Takeshita T, Kozlowski S, England RD, Brower R, Schneck J, Takahashi H, DeLisi C, Margulies DH, Berzofsky JA.

Int Immunol. 1993 Sep;5(9):1129-38.

PMID:
8241055
5.

An allosteric mechanism controls antigen presentation by the H-2K(b) complex.

Gakamsky DM, Boyd LF, Margulies DH, Davis DM, Strominger JL, Pecht I.

Biochemistry. 1999 Sep 14;38(37):12165-73.

PMID:
10508421
6.

Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.

Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S.

J Pept Sci. 1995 Mar-Apr;1(2):109-23.

PMID:
9222988
7.
8.

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

Schumacher TN, Heemels MT, Neefjes JJ, Kast WM, Melief CJ, Ploegh HL.

Cell. 1990 Aug 10;62(3):563-7.

PMID:
2199065
9.

Major histocompatibility complex conformational epitopes are peptide specific.

Catipović B, Dal Porto J, Mage M, Johansen TE, Schneck JP.

J Exp Med. 1992 Dec 1;176(6):1611-8.

10.

Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?

Mareeva T, Lebedeva T, Anikeeva N, Manser T, Sykulev Y.

J Biol Chem. 2004 Oct 22;279(43):44243-9.

11.

The fate of the three subunits of major histocompatibility complex class I molecules.

Neefjes JJ, Smit L, Gehrmann M, Ploegh HL.

Eur J Immunol. 1992 Jun;22(6):1609-14.

PMID:
1318200
12.

Efficient generation of major histocompatibility complex class I-peptide complexes using synthetic peptide libraries.

Stevens J, Wiesmüller KH, Barker PJ, Walden P, Butcher GW, Joly E.

J Biol Chem. 1998 Jan 30;273(5):2874-84.

13.
14.

High occupancy binding of antigenic peptides to purified, immunoadsorbed H-2Db beta 2m molecules.

Burshtyn DN, Barber BH.

J Immunol. 1993 Sep 15;151(6):3070-81.

PMID:
8397250
15.

Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120.

Li H, Natarajan K, Malchiodi EL, Margulies DH, Mariuzza RA.

J Mol Biol. 1998;283(1):179-91.

PMID:
9761682
16.

Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.

Chervonsky AV, Medzhitov RM, Denzin LK, Barlow AK, Rudensky AY, Janeway CA Jr.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10094-9.

17.
18.

Soluble class I MHC with beta2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma.

White J, Crawford F, Fremont D, Marrack P, Kappler J.

J Immunol. 1999 Mar 1;162(5):2671-6.

Supplemental Content

Support Center